XML 18 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Paid-in Capital [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Income (Loss), Net of Income Tax [Member]
Redeemable Noncontrolling Interests in Consolidated Entities/Temporary Stockholders' Equity [Member]
Balance, beginning of period at Dec. 31, 2020   $ 393 $ 1,682,939 $ (1,380,912)
Share-based compensation     31,043      
Net issuance of common stock   2 (2)      
Repurchases of common stock   (1) (25,817)    
Net income (loss)       465,808    
Dividends       (74,636)    
Effect of change in discount rate assumptions on the liability for future policy benefits         269,895  
Change in foreign currency translation adjustment         6,973  
Change in net unrealized investment gains (losses) during the period         (64,355)  
Acquisition of noncontrolling interest           8,438
Net income (loss) attributable to noncontrolling interests           (1,377)
Change in noncontrolling interests in consolidated entities, net           210
Redemption of noncontrolling interest in consolidated entities          
Balance, end of period at Dec. 31, 2021 $ 911,330 394 5,224 2,074,111 (1,168,399) 7,271
Share-based compensation     14,820      
Net issuance of common stock   1 (1)      
Repurchases of common stock   (7) (20,043) (83,813)    
Net income (loss) 115,039     115,039    
Dividends       (21,645)    
Effect of change in discount rate assumptions on the liability for future policy benefits         646,141  
Change in foreign currency translation adjustment         3,289  
Change in net unrealized investment gains (losses) during the period         (130,216)  
Net income (loss) attributable to noncontrolling interests (2,655)         (2,655)
Balance, end of period at Mar. 31, 2022 $ 1,434,895 388   2,083,692 (649,185) 4,616
Dividends declared per share $ 0.55          
Balance, beginning of period at Dec. 31, 2021 $ 911,330 394 5,224 2,074,111 (1,168,399) 7,271
Share-based compensation     33,624      
Net issuance of common stock   2 (2)      
Repurchases of common stock   (28) (41,079) (320,332)    
Net income (loss)       460,939    
Dividends       (83,783)    
Effect of change in discount rate assumptions on the liability for future policy benefits         1,372,022  
Change in foreign currency translation adjustment         (20,747)  
Change in net unrealized investment gains (losses) during the period         (304,645)  
Acquisition of noncontrolling interest          
Net income (loss) attributable to noncontrolling interests           (5,038)
Change in noncontrolling interests in consolidated entities, net          
Redemption of noncontrolling interest in consolidated entities     2,233     (2,233)
Balance, end of period at Dec. 31, 2022 2,009,534 368 2,130,935 (121,769)
Share-based compensation     16,622      
Net issuance of common stock   2 (2)      
Repurchases of common stock   (6) $ (16,620) (80,360)    
Net income (loss) 125,106     125,106    
Dividends       (23,910)    
Effect of change in discount rate assumptions on the liability for future policy benefits         (142,974)  
Change in foreign currency translation adjustment         998  
Change in net unrealized investment gains (losses) during the period         32,711  
Balance, end of period at Mar. 31, 2023 $ 1,921,101 $ 364   $ 2,151,771 $ (231,034)  
Dividends declared per share $ 0.65